VENTANA PD-L1 (SP142) ASSAY
Report
- Report Number
- 2028492-2023-00008
- Event Type
- Malfunction
- Date Received
- February 2, 2023
- Date of Event
- January 12, 2023
- Report Date
- February 2, 2023
- Manufacturer
- VENTANA MEDICAL SYSTEMS INC
- Product Code
- PLS
- PMA / PMN Number
- P160002
- Removal / Correction Number
- 2028492-11-09-2022-003-C
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
IN THIS CASE, THE REAGENT LOT NUMBER WAS NOT PROVIDED, HOWEVER, ROCHE OBSERVED UNACCEPTABLE, LIGHT STAINING WITH SOME VENTANA PD-L1 (SP142) ON-MARKET LOTS, DURING INTERNAL COMPARISON STUDIES. LIGHT STAINING AFFECTS THE BORDERLINE OF POSITIVE VERSUS NEGATIVE TEST RESULTS. AN ON-GOING INVESTIGATION HAS DETERMINED THE ROOT CAUSE IS RELATED TO VARIABILITY IN THE SELECTION OF ANTIBODY CONCENTRATION IN RAW MATERIALS, AFFECTING SPECIFIC VENTANA PD-L1 (SP142) ASSAY LOTS MADE WITH THE IMPACTED RAW MATERIALS. A NOTIFICATION HAS BEEN SENT TO US CUSTOMERS INFORMING THEM OF THE ISSUE TO IMMEDIATELY DISCONTINUE THE USE OF AND DISCARD ANY REMAINING INVENTORY OF SPECIFIC IMPACTED LOTS AND INFORMING OF AN UPDATED DATE OF EXPIRATION FOR CERTAIN LOTS.
A CUSTOMER FROM JAPAN ALLEGED DISCREPANT RESULTS WITH THE VENTANA PD-L1 (SP142) ASSAY FOR FOUR LUNG SAMPLES. EACH OF THE FOUR ALLEGED SAMPLES INITIALLY GENERATED A NEGATIVE RESULT WHICH WAS REPORTED OUT. THE SAMPLES WERE THEN RETESTED AND GENERATED A POSITIVE RESULT. TO DATE, NO HARM OR INJURY IS ALLEGED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 384479 | VENTANA PD-L1 (SP142) ASSAY | PROGRAMMED DEATH-LIGAND 1 (PD-L1) IVD, ANTIBODY | PLS | VENTANA MEDICAL SYSTEMS INC | NA | ASKU |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown |